BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26759497)

  • 1. Shedding of Oral Poliovirus Vaccine (OPV) by HIV-Infected and -Uninfected Mothers of OPV-Vaccinated Zimbabwean Infants.
    Holubar M; Troy SB; Nathoo K; Stranix-Chibanda L; Musingwini G; Srinivas N; Huang C; Junn A; Halpern MS; Maldonado YA
    J Pediatric Infect Dis Soc; 2017 Mar; 6(1):105-108. PubMed ID: 26759497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants.
    Troy SB; Musingwini G; Halpern MS; Huang C; Stranix-Chibanda L; Kouiavskaia D; Shetty AK; Chumakov K; Nathoo K; Maldonado YA
    J Infect Dis; 2013 Aug; 208(4):672-8. PubMed ID: 23661792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric HIV Infection and Decreased Prevalence of OPV Point Mutations Linked to Vaccine-associated Paralytic Poliomyelitis.
    Halpern MS; Altamirano J; Maldonado Y
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S78-S84. PubMed ID: 30376083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic response to oral polio vaccine in human immunodeficiency virus-infected and uninfected Zimbabwean children.
    Gnanashanmugam D; Troy SB; Musingwini G; Huang C; Halpern MS; Stranix-Chibanda L; Shetty AK; Kouiavskaia D; Nathoo K; Chumakov K; Maldonado YA
    Pediatr Infect Dis J; 2012 Feb; 31(2):176-80. PubMed ID: 22146742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses to oral poliovirus vaccine in HIV-exposed uninfected Zimbabwean infants.
    Church JA; Rukobo S; Govha M; Carmolli MP; Diehl SA; Chasekwa B; Ntozini R; Mutasa K; Humphrey JH; Kirkpatrick BD; Prendergast AJ
    Hum Vaccin Immunother; 2017 Nov; 13(11):2543-2547. PubMed ID: 28857649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced Poliovirus vaccine neutralising-antibody titres in infants with maternal HIV-exposure.
    Sanz-Ramos M; Manno D; Kapambwe M; Ndumba I; Musonda KG; Bates M; Chibumbya J; Siame J; Monze M; Filteau S; Gompels UA;
    Vaccine; 2013 Apr; 31(16):2042-9. PubMed ID: 23474309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodevelopmental impairment among infants born to mothers infected with human immunodeficiency virus and uninfected mothers from three peri-urban primary care clinics in Harare, Zimbabwe.
    Kandawasvika GQ; Ogundipe E; Gumbo FZ; Kurewa EN; Mapingure MP; Stray-Pedersen B
    Dev Med Child Neurol; 2011 Nov; 53(11):1046-52. PubMed ID: 22014323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa.
    Pavlov DN; Van Zyl WB; Kruger M; Blignaut L; Grabow WO; Ehlers MM
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):23-30. PubMed ID: 16290028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Oral Polio Vaccine and the Global Incidence of Mother-to-Child Human Immunodeficiency Virus Transmission.
    Habibzadeh F; Yadollahie M; Simi A
    Front Public Health; 2022; 10():878298. PubMed ID: 35812500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of HIV-exposure and timing of anti-retroviral treatment on immunogenicity of trivalent live-attenuated polio vaccine in infants.
    Moonsamy S; Suchard M; Madhi SA
    PLoS One; 2019; 14(4):e0215079. PubMed ID: 31002702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire.
    Hennessey KA; Lago H; Diomande F; Akoua-Koffi C; Caceres VM; Pallansch MA; Kew OM; Nolan M; Zuber PL
    J Infect Dis; 2005 Dec; 192(12):2124-8. PubMed ID: 16288377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of poliovirus shedding following oral vaccination as measured by quantitative reverse transcription-PCR versus culture.
    Taniuchi M; Begum S; Uddin MJ; Platts-Mills JA; Liu J; Kirkpatrick BD; Chowdhury AH; Jamil KM; Haque R; Petri WA; Houpt ER
    J Clin Microbiol; 2015 Jan; 53(1):206-11. PubMed ID: 25378579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children.
    Hassan J; Wangai L; Borus P; Khayeka-Wandabwa C; Karani LW; Kithinji M; Kiptoo M
    BMC Res Notes; 2017 Nov; 10(1):555. PubMed ID: 29100529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?
    Ogra PL
    Public Health Rev; 1993-1994; 21(1-2):143-50. PubMed ID: 8041881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains.
    Laassri M; Lottenbach K; Belshe R; Wolff M; Rennels M; Plotkin S; Chumakov K
    J Infect Dis; 2005 Dec; 192(12):2092-8. PubMed ID: 16288372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants.
    Asturias EJ; Dueger EL; Omer SB; Melville A; Nates SV; Laassri M; Chumakov K; Halsey NA
    J Infect Dis; 2007 Sep; 196(5):692-8. PubMed ID: 17674310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India.
    Grassly NC; Jafari H; Bahl S; Durrani S; Wenger J; Sutter RW; Aylward RB
    J Infect Dis; 2009 Sep; 200(5):794-801. PubMed ID: 19624278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine.
    Taffs RE; Enterline JC; Rusmil K; Muhilal ; Suwardi SS; Rustama D; Djatnika ; Cobra C; Semba RD; Cohen N; Asher DM
    Bull World Health Organ; 1999; 77(6):484-91. PubMed ID: 10427933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.